T1	Participants 385 648	Adult patients who underwent laparotomy for bowel resection scheduled for opioid-based intravenous patient-controlled analgesia received oral alvimopan or placebo preoperatively and twice daily postoperatively until hospital discharge or for 7 postoperative days.
T2	Participants 1538 1574	patients undergoing bowel resection.
